Literature DB >> 28706749

Memories of John Fahey and His Contributions to the Multicenter AIDS Cohort Study (MACS).

John Phair1, Roger Detels2, Joseph Margolick3, Charles Rinaldo4, Lisa Jacobson3, Otoniel Martínez-Maza2,5, Steven Wolinsky1, Alvaro Muñoz3.   

Abstract

John Fahey was an integral member of the small group of investigators who developed the Multicenter AIDS Cohort Study (MACS) in the early 1980s. A major research theme in the MACS was defining immune system changes in men at risk for developing AIDS. John's experience and expertise provided a solid grounding for the immunologic investigations conducted in the MACS. Additionally, he contributed enormously to the science of the MACS and pioneered the critical evaluation of serologic methods of documenting infection with HIV and T cell phenotyping. Perhaps most importantly, John recruited key new investigators to the MACS, and worked closely with the original MACS investigators to create a structure that promoted scientific innovation, openness, and the ability to quickly respond to emerging research themes.

Entities:  

Keywords:  AIDS; immunology; natural history

Year:  2015        PMID: 28706749      PMCID: PMC5505340          DOI: 10.1615/ForumImmunDisTher.v6.i1-2.110

Source DB:  PubMed          Journal:  For Immunopathol Dis Therap        ISSN: 2151-8017


  7 in total

1.  Detailed immunophenotype of CD8+ memory cytotoxic T-lymphocytes (CTL) against HIV-1 with respect to expression of CD45RA/RO, CD62L and CD28 antigens.

Authors:  J V Giorgi; M A Hausner; L E Hultin
Journal:  Immunol Lett       Date:  1999-03       Impact factor: 3.685

2.  Origin of CD4 T cell levels of 200 cells/μl as the key marker for AIDS diagnosis and therapy: was 186 cells/μl more precise, but less useful?

Authors:  John L Fahey
Journal:  AIDS       Date:  2011-01-02       Impact factor: 4.177

3.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

4.  Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity.

Authors:  O Martínez-Maza; E Crabb; R T Mitsuyasu; J L Fahey; J V Giorgi
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

5.  TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.

Authors:  Yu Guo; Basile Siewe; Marta Epeldegui; Roger Detels; Alan L Landay; Otoniel Martínez-Maza
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

6.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

7.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

Authors:  J Phair; A Muñoz; R Detels; R Kaslow; C Rinaldo; A Saah
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.